Measuring psychotic depression

Acta Psychiatrica Scandinavica

Volumn 129, Issue 3, 2014, Pages 211-220

  Ostergaard S D ^a,b   Meyers, B S ^c   Flint, A J ^d,e   Mulsant, B H ^e,f,g   Whyte, E M ^g   Ulbricht, C M ^h   Bech, P ⁱ   Rothschild, A J ^j  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ Mental Health Services CPH   (Denmark)

^j University of Massachusetts   (United States)

more..

Author keywords

Affective disorders; Depression; Psychometrics; Psychoses

Indexed keywords

ADULT; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL EVALUATION; CLINICAL GLOBAL IMPRESSION SCALE; CORRELATION COEFFICIENT; DEPRESSION; DEPRESSIVE PSYCHOSIS; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; RATING SCALE; SCORING SYSTEM; AFFECTIVE DISORDERS, PSYCHOTIC; DEPRESSIVE DISORDER; DEVICES; MIDDLE AGED; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS;

ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; BRIEF PSYCHIATRIC RATING SCALE; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84893627739     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12165     Document Type: Article

References (67)

1. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: WHO, 1993.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association, 2000.
3. Ostergaard SD, Rothschild AJ, Uggerby P, Munk-Jorgensen P, Bech P, Mors O. Considerations on the ICD-11 classification of psychotic depression. Psychother Psychosom 2012;81:135-144.
4. Rothschild AJ. Clinical manual for diagnosis and treatment of psychotic depression. Washington DC, USA: American Psychiatric Publishing, Inc., 2009.
5. Ostergaard SD, Petrides G, Dinesen PT et al. The Association between physical morbidity and subtypes of severe depression. Psychother Psychosom 2013;82:45-52.
6. Ostergaard SD, Waltoft BL, Mortensen PB, Mors O. Environmental and familial risk factors for psychotic and non-psychotic severe depression. J Affect Disord 2013;147:232-240.
7. Domschke K, Lawford B, Young R et al. Dysbindin (DTNBP1) - a role in psychotic depression? J Psychiatr Res 2010;45:588-595.
8. Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 1997;154:1497-1503.
9. Posener JA, Debattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000;57:755-760.
10. Cubells JF, Price LH, Meyers BS et al. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 2002;51:358-364.
11. Meyers BS, Alexopoulos GS, Kakuma T et al. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression. Biol Psychiatry 1999;45:448-452.
12. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L. Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 2007;68:1411-1417.
13. Ostergaard SD, Bille J, Soltoft-Jensen H, Lauge N, Bech P. The validity of the severity-psychosis hypothesis in depression. J Affect Disord 2012;140:48-56.
14. Coryell W, Leon A, Winokur G et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996;153:483-489.
15. Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry 1993;34:392-400.
16. Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 1991;48:1075-1081.
17. Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, Nelson JC. Psychotic depression and mortality. Am J Psychiatry 2003;160:574-576.
18. Park MH, Kim TS, Yim HW et al. Clinical characteristics of depressed patients with a history of suicide attempts: results from the CRESCEND study in South Korea. J Nerv Ment Dis 2010;198:748-754.
19. Ostergaard SD, Bertelsen A, Nielsen J, Mors O, Petrides G. The association between psychotic mania, psychotic depression and mixed affective episodes among 14, 529 patients with bipolar disorder. J Affect Disord 2013;147:44-50.
20. Spiker DG, Kupfer DJ. Placebo response rates in psychotic and nonpsychotic depression. J Affect Disord 1988;14:21-23.
21. Glassman AH, Roose SP. Delusional depression. A distinct clinical entity? Arch Gen Psychiatry 1981;38:424-427.
22. Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 1981;138:328-333.
23. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733-745.
24. Nelson WH, Khan A, Orr WW Jr. Delusional depression. Phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 1984;6:297-306.
25. Spiker DG, Weiss JC, Dealy RS et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430-436.
26. Brown RP, Frances A, Kocsis JH, Mann JJ. Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 1982;170:635-637.
27. Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987;48:197-200.
28. Petrides G, Fink M, Husain MM et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;17:244-253.
29. Loo CK, Mahon M, Katalinic N, Lyndon B, Hadzi-Pavlovic D. Predictors of response to ultrabrief right unilateral electroconvulsive therapy. J Affect Disord 2011;130:192-7.
30. Birkenhager TK, Pluijms EM, Lucius SA. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 2003;74:191-195.
31. Meyers BS, Flint AJ, Rothschild AJ et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 2009;66:838-847.
32. Wijkstra J, Burger H, van den Broek WW et al. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Acta Psychiatr Scand 2010;121:190-200.
33. Rothschild AJ, Williamson DJ, Tohen MF et al. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004;24:365-373.
34. Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry 2012;73:486-496.
35. Leadholm AK, Rothschild AJ, Nolen WA, Bech P, Munk-Jorgensen P, Ostergaard SD. The treatment of psychotic depression: is there consensus among guidelines and psychiatrists? J Affect Disord 2013;145:214-220.
36. Feinstein AR. T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. Circulation 1982;66:1-5.
37. Fava GA, Tomba E, Sonino N. Clinimetrics: the science of clinical measurements. Int J Clin Pract 2012;66:11-15.
38. Bech P. Clinical psychometrics. Oxford, UK: Wiley-Blackwell, 2012.
39. Stochl J, Jones PB, Croudace TJ. Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol 2012;. doi:10.1186/1471-2288-12-74.
40. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
41. Bech P. Pharmacological treatment of depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive disorders. WPA series evidence and experience in psychiatry. Chichester: John Wiley & Sons, 1999.
42. Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975;51:161-170.
43. Bech P, Allerup P, Gram LF et al. The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290-299.
44. Licht RW, Qvitzau S, Allerup P, Bech P. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005;111:144-149.
45. Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. J Affect Disord 2011;132:396-400.
46. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1-100.
47. Bech P. Is the antidepressive effect of second-generation antidepressants a myth? Psychol Med 2010;40:181-186.
48. Bech P. The three-fold Hamilton Depression Scale: an editorial comment to Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression (1). Acta Psychiatr Scand 2012;125:423-424.
49. Bech P, Boyer P, Germain JM et al. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry 2010;43:271-276.
50. Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatr Scand 2012;125:342-348.
51. Bech P, Allerup P, Larsen ER, Csillag C, Licht R. Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained. Acta Psychiatr Scand 2013;127:328-329.
52. Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 2006;188:410-415.
53. Preti A, Bonventre E, Ledda V, Petretto DR, Masala C. Hallucinatory experiences, delusional thought proneness, and psychological distress in a nonclinical population. J Nerv Ment Dis 2007;195:484-491.
54. Langer AI, Cangas AJ, Serper M. Analysis of the multidimensionality of hallucination-like experiences in clinical and nonclinical Spanish samples and their relation to clinical symptoms: implications for the model of continuity. Int J Psychol 2011;46:46-54.
55. Johns LC. Hallucinations in the general population. Curr Psychiatry Rep 2005;7:162-167.
56. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001;21:1125-1141.
57. Meyers BS, English J, Gabriele M et al. A delusion assessment scale for psychotic major depression: reliability, validity, and utility. Biol Psychiatry 2006;60:1336-1342.
58. Williams JB, Kobak KA, Bech P et al. The GRID-HAMD: standardization of the Hamilton depression rating scale. Int Clin Psychopharmacol 2008;23:120-129.
59. Spitzer R, Endicott J. Schedule for affective disorders and schizophrenia, 3rd edn. New York: Biometrics Research Dept, New York State Psychiatric Institute, 1979.
60. Guy W eds. Clinical global impressions scale. In: ECDEU assessment manual for psychopharmacology. Rockville, MD, USA: US Department of Health, Education and Welfare pub no (AMD) 76-338, NIMH, 1976.
61. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
62. Hotelling H. Rotations in psychology and the statistical revolution. Science 1942;95:504-507.
63. Hotelling H. Analysis of a complex of statistical variables with principal components. J Educ Psychol 1933;24:417-441.
64. Mokken RJ. Theory and practice of scale analysis. Berlin, Germany: Mouton, 1971.
65. Loevinger J. Objective tests as instruments of psychological theory. Biol Psychiatry 1957;3:635-694.
66. Molenaar IW, Debels P, Sijtsna K. User's manual MSP, a program for Mokken Scale analyses for Polytomous Items (version 3.0). Groeningen, The Netherlands: ProGAMMA, 1994.
67. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA. Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005;4:CD004044.